twistbioscience.com - TWST Total Company Value-to-Revenue Ratio

The EV-to-revenue ratio of Twist Bioscience (TWST) demonstrates the company's resilience to market shocks, with the 15504.39 value confirming the current level. The business relies on stable demand from laboratories in the synthetic biology sector, which is minimally affected by economic cycles. Consistent scientific grants ensure macro-stability, while the expansion of the Express line and cost optimization for DNA platforms contribute to margin growth.
twistbioscience.com - analytical breakdowns and key metrics (TWST)

An investment audit of Twist Bioscience (TWST) requires a precise analysis of market value relative to operating revenues. This metric is calculated as the ratio of enterprise value (EV) to revenue, excluding the impact of debt load on capitalization. For Twist Bioscience (TWST), this figure reflects a premium for owning unique silicon-based DNA synthesis technologies. The EV/Sales historical trend demonstrates how the market values the company's technological superiority amidst stringent government regulation.